Felipe Rodríguez de Castro-rekin lankidetzan egindako argitalpenak (12)

2016

  1. Neumonía adquirida en la comunidad

    Neumología clínica (Elsevier España), pp. 276-286

  2. Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome

    Journal of Infection, Vol. 73, Núm. 5, pp. 419-426

2015

  1. Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia

    Annals of the American Thoracic Society, Vol. 12, Núm. 10, pp. 1482-1489

2014

  1. Tobacco smoking increases the risk for death from pneumococcal pneumonia

    Chest, Vol. 146, Núm. 4, pp. 1029-1037

2012

  1. Compliance with guidelines-recommended processes in pneumonia: Impact of health status and initial signs

    PLoS ONE, Vol. 7, Núm. 5

  2. Initial management of pneumonia and sepsis: Factors associated with improved outcome

    European Respiratory Journal, Vol. 39, Núm. 1, pp. 156-162

2008

  1. Resistant pneumococcal pneumonia

    Infectious Diseases in Clinical Practice, Vol. 16, Núm. 6, pp. 368-375

2005

  1. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)

    Archivos de Bronconeumologia, Vol. 41, Núm. 5, pp. 272-289

  2. Guidelines for the treatment of community-acquired pneumonia: Predictors of adherence and outcome

    American Journal of Respiratory and Critical Care Medicine, Vol. 172, Núm. 6, pp. 757-762

2004

  1. Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors

    Clinical Infectious Diseases, Vol. 38, Núm. 6, pp. 787-798

  2. Reaching stability in community-acquired pneumonia: The effects of the severity of disease, treatment, and the characteristics of patients

    Clinical Infectious Diseases, Vol. 39, Núm. 12, pp. 1783-1790

  3. Risk factors of treatment failure in community acquired pneumonia: Implications for disease outcome

    Thorax, Vol. 59, Núm. 11, pp. 960-965